Methyl 2-(((benzyloxy)carbonyl)amino)-7-oxo-6-azaspiro[3.4]octane-8-carboxylate
95%
- Product Code: 122913
CAS:
1823417-67-9
| Molecular Weight: | 332.35 g./mol | Molecular Formula: | C₁₇H₂₀N₂O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28119008 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, sealed |
Product Description:
This compound is primarily used in organic synthesis as an intermediate in the development of more complex molecules, particularly in pharmaceutical research. Its structure, featuring both a spirocyclic system and a carbamate group, makes it valuable for constructing biologically active compounds. It is often employed in the synthesis of potential drug candidates, especially those targeting enzyme inhibition or receptor modulation. The presence of the benzyloxycarbonyl (Cbz) protecting group allows for selective deprotection during multi-step synthetic processes, enabling precise control over the final product's structure. Additionally, its unique spirocyclic framework is explored in the design of novel therapeutic agents with improved stability and specificity.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $665.40 |
+
-
|
| 0.250 | 10-20 days | $1,224.61 |
+
-
|
Methyl 2-(((benzyloxy)carbonyl)amino)-7-oxo-6-azaspiro[3.4]octane-8-carboxylate
This compound is primarily used in organic synthesis as an intermediate in the development of more complex molecules, particularly in pharmaceutical research. Its structure, featuring both a spirocyclic system and a carbamate group, makes it valuable for constructing biologically active compounds. It is often employed in the synthesis of potential drug candidates, especially those targeting enzyme inhibition or receptor modulation. The presence of the benzyloxycarbonyl (Cbz) protecting group allows for selective deprotection during multi-step synthetic processes, enabling precise control over the final product's structure. Additionally, its unique spirocyclic framework is explored in the design of novel therapeutic agents with improved stability and specificity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :